U.S. stock futures showed modest gains Tuesday morning, with the Dow futures climbing around 0.1%. But not everyone was joining the party—several stocks faced heavy selling pressure before the opening bell.

The Earnings Beat That Didn't Matter

Leading the decliners was Signet Jewelers Ltd (SIG), which dropped 3.9% to $92.01 in pre-market trading. Here's the puzzling part: the jewelry retailer actually delivered solid third-quarter results, posting earnings of 63 cents per share that handily beat the analyst consensus of 29 cents. Revenue came in at $1.391 billion, topping expectations of $1.370 billion.

Sometimes beating estimates just isn't enough—investors might have been looking for stronger guidance or worried about the broader retail environment heading into the holiday season.

Biotech Takes a Hit

Janux Therapeutics Inc (JANX) experienced the steepest decline, plunging 39.7% to $20.50 after announcing updated interim data for its JANX007 drug candidate. The market's harsh reaction suggests the clinical trial results fell short of investor expectations.

Volatility Continues

Several stocks that experienced dramatic moves Monday saw continued turbulence. Coincheck Group NV (CNCK) dipped 17.6% to $6.50 after surging 143% the previous day. SMX (Security Matters) PLC (SMX) tumbled another 15.2% to $33.08, following Monday's 36% decline. Meanwhile, Ambitions Enterprise Management Co LLC (AHMA) declined 14.2% to $12.31 after gaining more than 198% on Monday.

Other Notable Decliners

BW LPG Ltd (BWLP) fell 6.4% to $11.73 after posting third-quarter results. The shipping company's earnings apparently didn't impress investors.

IREN Ltd (IREN) declined 4.9% to $46.17 following news of a registered direct offering of ordinary shares, plus $1 billion in convertible senior notes due 2032 and $1 billion in notes due 2033. The capital raise likely signals dilution concerns for existing shareholders.

Finally, Symbotic Inc (SYM) shares fell 5% to $81.00, even though the company recently reported better-than-expected fourth-quarter results and issued first-quarter sales guidance with its midpoint above estimates. Sometimes good news gets priced in quickly.